Nemaura Medical Launches Metabolic Health Program for Employers and Insurers
13 janv. 2022 08h30 HE | Nemaura Medical, Inc
Launch into commercial markets offers opportunities for faster and wider adoption of Miboko program Loughborough, England, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)...
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
15 nov. 2021 09h30 HE | Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches Beta Version of Its Metabolic Health Program
29 sept. 2021 08h30 HE | Nemaura Medical, Inc
MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England, Sept. 29, 2021 (GLOBE...